The AI drug discovery unicorn aims to move beyond early research and build fully autonomous intelligence for real-world clinical development.
Beijing, 4 February 2026 –...
The investment will support advanced human-like cell models for neuroscience, eye, and heart research.
Edinburgh, Scotland, 14 January 2026 - Axol Bioscience Ltd. (Axol), a...
From rapid FDA approvals to AI-powered diagnostics and major metabolic partnerships, life sciences innovation is accelerating across drugs, devices, and regulation.
New York, US, 13...
Genentech, a member of the Roche Group, had officially announced the launch of its Direct-to-Patient (DTP) program, which applies to Xofluza® (baloxavir marboxil), a...
